Accenture acquires Octagon Research Solutions

Accenture (NYSE:ACN) has completed its acquisition of Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry based in Wayne, Pa. The acquisition was announced on Aug. 2.

The acquisition enhances Accenture's existing clinical services capabilities - including clinical data management, clinical programming and safety case processing, among others - and adds regulatory submission services, thereby extending Accenture's business process outsourcing capabilities for the pharmaceutical industry. As a result, Accenture can now provide the first comprehensive clinical and regulatory services to pharmaceutical companies globally, helping them get medicines to market more quickly and cost effectively.

"Our pharmaceutical clients around the world are looking for proven clinical and regulatory services that can improve the efficiency and effectiveness of their drug development business," said David Boath, North American managing director for Accenture's Life Sciences industry group. "With Octagon's deep regulatory expertise and proprietary software - coupled with Accenture's global delivery network and R&D experience across the in the pharmaceutical industry - we can now offer software-enabled clinical and regulatory services solution from the initial clinical protocol design through to regulatory submission."